Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 7.67 -0.23 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.90 | 52 Week High | $9.58 | |||
| Open | $7.96 | 52 Week Low | $2.34 | |||
| Day High | $7.96 | P/E | N/A | |||
| Day Low | $7.65 | EPS | $-0.34 | |||
| Volume | 2,485 | |||||
